Antitumor Activity of Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor, in ETV6-NTRK3–Positive Acute Myeloid Leukemia
暂无分享,去创建一个
E. Pomari | I. Silverman | Kristen M. Smith | C. Frasson | P. Bonvini | G. Li | P. Fagan | G. Germano | C. Walsh
暂无分享,去创建一个
E. Pomari | I. Silverman | Kristen M. Smith | C. Frasson | P. Bonvini | G. Li | P. Fagan | G. Germano | C. Walsh